Physician profile
Joseph E Cerbone
NPI 1235173709
$1,186.23
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $216 · 2021: $322 · 2022: $231 · 2023: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288 · Education: $14.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.26 |
| Education | $14.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $214.48 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $165.45 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $122.26 | 2019-2022 | |
| Genzyme Corporation | $106.84 | 2019-2023 | |
| Abbvie INC. | $102.06 | 2019-2023 | Rinvoq |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $65.19 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $62.56 | 2021-2023 | |
| Leo Pharma INC. | $61.17 | 2022-2023 | Adbry |
| Janssen Biotech, INC. | $55.62 | 2022-2023 | Remicade, Stelara, Simponi Aria |
| Dermavant Sciences, INC. | $48.50 | 2023 | Vtama |
| Regeneron Healthcare Solutions, INC. | $41.96 | 2020-2021 | |
| Epi Health, LLC | $35.45 | 2019-2021 | |
| Dermira, INC. | $24.65 | 2019-2021 | |
| Galderma Laboratories, L.P. | $23.79 | 2020 | |
| Incyte Corporation | $17.09 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.87 | 2022 | |
| Arcutis Biotherapeutics, INC. | $13.01 | 2023 | |
| Encore Dermatology INC. | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cerbone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.